Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00B3VWM098
| Stock Name / Fund | iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | CUS1(GBX) LSE |
| ETF Ticker | CUSS(USD) LSE |
| ETF Ticker | SXRG(EUR) F |
| ETF Ticker | CSUSS.MI(EUR) CXE |
| ETF Ticker | CSUSSz(USD) CXE |
| ETF Ticker | CUSS.LS(USD) CXE |
| ETF Ticker | CSUSS(EUR) ETF Plus |
| ETF Ticker | CUS1.L(GBP) LSE |
| ETF Ticker | CUSS.L(GBP) LSE |
Holdings detail for QURE
| Stock Name | Uniqure NV |
| Ticker | QURE(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | NL0010696654 |
Show aggregate QURE holdings
News associated with QURE
- uniQure (NASDAQ:QURE) Receives “Buy” Rating from Chardan Capital
- Chardan Capital reaffirmed their buy rating on shares of uniQure (NASDAQ:QURE – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. They currently have a $35.00 target price on the biotechnology company’s stock. Several other research analysts also recently commented on QURE. Wall Street Zen raised uniQure from a “sell” rating […] - 2025-09-09 03:10:46
- uniQure (NASDAQ:QURE) Upgraded at Wall Street Zen
- Wall Street Zen upgraded shares of uniQure (NASDAQ:QURE – Free Report) from a sell rating to a hold rating in a report issued on Saturday morning. QURE has been the subject of several other research reports. Guggenheim reiterated a “buy” rating and issued a $28.00 price objective on shares of uniQure in a research note […] - 2025-08-05 03:00:52
- uniQure N.V. (NASDAQ:QURE) Receives $37.82 Average Target Price from Analysts
- uniQure N.V. (NASDAQ:QURE – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, six have given a buy recommendation and two have assigned a strong buy recommendation to the company. […] - 2025-07-31 03:13:08
- Analysts See 19% Gains Ahead For FHLC
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-14 09:54:06
- uniQure (NASDAQ:QURE) Share Price Crosses Below Fifty Day Moving Average Following Insider Selling
- Shares of uniQure N.V. (NASDAQ:QURE – Get Free Report) crossed below its fifty day moving average during trading on Monday after an insider sold shares in the company. The stock has a fifty day moving average of $14.29 and traded as low as $13.65. uniQure shares last traded at $13.95, with a volume of 1,978,275 […] - 2025-06-24 02:20:53
- uniQure (NASDAQ:QURE) Shares Acquired by Assenagon Asset Management S.A.
- Assenagon Asset Management S.A. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 355.2% during the first quarter, HoldingsChannel reports. The fund owned 334,894 shares of the biotechnology company’s stock after buying an additional 261,323 shares during the period. Assenagon Asset Management S.A.’s holdings in uniQure were worth $3,550,000 at the end of the […] - 2025-06-16 05:08:54
- uniQure (NASDAQ:QURE) Receives $37.82 Average Price Target from Analysts
- uniQure (NASDAQ:QURE – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the […] - 2025-06-11 04:20:59
- Bank of America Corp DE Sells 182,421 Shares of uniQure (NASDAQ:QURE)
- Bank of America Corp DE cut its holdings in uniQure (NASDAQ:QURE – Free Report) by 72.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 69,064 shares of the biotechnology company’s stock after selling 182,421 shares during the period. Bank of America Corp DE’s holdings in uniQure were worth $1,220,000 as of its most recent […] - 2025-06-06 04:37:00
- Stock Traders Buy Large Volume of uniQure Call Options (NASDAQ:QURE)
- uniQure (NASDAQ:QURE – Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors bought 8,961 call options on the company. This is an increase of 314% compared to the average volume of 2,162 call options. Institutional Inflows and Outflows Several hedge funds and other institutional investors have recently bought and sold […] - 2025-06-05 02:26:44
- uniQure Sees Unusually High Options Volume (NASDAQ:QURE)
- uniQure (NASDAQ:QURE – Get Free Report) saw unusually large options trading on Wednesday. Stock traders acquired 3,615 put options on the company. This is an increase of approximately 102% compared to the average volume of 1,792 put options. Analysts Set New Price Targets QURE has been the topic of a number of research analyst reports. […] - 2025-05-23 02:01:04
- uniQure (NASDAQ:QURE) Upgraded at Cantor Fitzgerald
- Cantor Fitzgerald upgraded shares of uniQure (NASDAQ:QURE – Free Report) to a strong-buy rating in a research note issued to investors on Monday,Zacks.com reports. Cantor Fitzgerald also issued estimates for uniQure’s FY2025 earnings at ($2.76) EPS. Several other research analysts have also recently commented on QURE. HC Wainwright restated a “buy” rating and issued a […] - 2025-05-22 04:50:48
- Ameriprise Financial Inc. Sells 333,968 Shares of uniQure (NASDAQ:QURE)
- Ameriprise Financial Inc. decreased its holdings in shares of uniQure (NASDAQ:QURE – Free Report) by 38.6% in the fourth quarter, Holdings Channel reports. The firm owned 531,830 shares of the biotechnology company’s stock after selling 333,968 shares during the quarter. Ameriprise Financial Inc.’s holdings in uniQure were worth $9,392,000 at the end of the most […] - 2025-05-21 04:26:50
- Chardan Capital Reaffirms “Buy” Rating for uniQure (NASDAQ:QURE)
- uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Chardan Capital in a report released on Monday,Benzinga reports. They currently have a $38.00 price objective on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 196.64% from the stock’s previous close. QURE […] - 2025-05-14 02:56:49
- uniQure (NASDAQ:QURE) Earns Buy Rating from Guggenheim
- uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Guggenheim in a note issued to investors on Monday,Benzinga reports. They currently have a $28.00 price target on the biotechnology company’s stock. Guggenheim’s price objective suggests a potential upside of 118.58% from the stock’s current price. A number of […] - 2025-05-14 02:56:48
- uniQure (NASDAQ:QURE) Position Lowered by Stifel Financial Corp
- Stifel Financial Corp reduced its position in uniQure (NASDAQ:QURE – Free Report) by 7.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,168 shares of the biotechnology company’s stock after selling 4,828 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-09 05:28:58
- uniQure (NASDAQ:QURE) Short Interest Up 19.8% in April
- uniQure (NASDAQ:QURE – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 5,260,000 shares, a growth of 19.8% from the March 31st total of 4,390,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the […] - 2025-05-05 04:58:48
- uniQure (NASDAQ:QURE) Earns “Buy” Rating from HC Wainwright
- uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $70.00 target price on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 386.45% from […] - 2025-04-23 02:34:42
- Pre-Market Most Active for Apr 17, 2025 : HTZ, TSLL, NVDA, TQQQ, SQQQ, QURE, TSM, HIMS, NVO, UNH, BABA, NIO
- The NASDAQ 100 Pre-Market Indicator is up 152.15 to 18,409.79. The total Pre-Market volume is currently 187,788,799 shares traded.The following are the most active stocks for the pre-market session: Hertz Global Holdings, Inc (HTZ) is +1.35 at $7.06, with 12,622,622 shares trade - 2025-04-17 09:28:52
- Alliancebernstein L.P. Increases Stock Position in uniQure (NASDAQ:QURE)
- Alliancebernstein L.P. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 14.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 203,919 shares of the biotechnology company’s stock after acquiring an additional 25,319 shares during the quarter. Alliancebernstein L.P.’s holdings in uniQure were worth $3,601,000 as of its most recent filing with […] - 2025-04-15 04:50:49
- uniQure (NASDAQ:QURE) Coverage Initiated at Chardan Capital
- Equities researchers at Chardan Capital initiated coverage on shares of uniQure (NASDAQ:QURE – Get Free Report) in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $38.00 price target on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 257.82% from […] - 2025-04-03 04:26:59
- Analysts Set uniQure (NASDAQ:QURE) PT at $38.89
- Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-03-28 04:56:46
- uniQure (NASDAQ:QURE) Rating Increased to Sell at StockNews.com
- uniQure (NASDAQ:QURE – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Tuesday. QURE has been the subject of a number of other research reports. Cantor Fitzgerald lifted their target price on shares of uniQure from $28.00 to $58.00 […] - 2025-03-13 04:26:52
- uniQure (NASDAQ:QURE) Receives Buy Rating from HC Wainwright
- uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $70.00 price target on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 478.99% from the stock’s previous close. Several other equities research […] - 2025-03-06 06:56:12
- William Blair Predicts uniQure’s Q1 Earnings (NASDAQ:QURE)
- uniQure (NASDAQ:QURE – Free Report) – William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of uniQure in a report released on Thursday, February 27th. William Blair analyst S. Corwin now anticipates that the biotechnology company will post earnings of ($1.48) per share for the quarter, down from their prior forecast […] - 2025-03-04 04:33:08
- Y Intercept Hong Kong Ltd Lowers Stake in uniQure (NASDAQ:QURE)
- Y Intercept Hong Kong Ltd lowered its stake in shares of uniQure (NASDAQ:QURE – Free Report) by 50.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 28,319 shares of the biotechnology company’s stock after selling 29,014 shares during the period. Y Intercept Hong Kong Ltd owned […] - 2025-03-03 06:28:55
- uniQure (NASDAQ:QURE) Receives $40.00 Average Price Target from Analysts
- Shares of uniQure (NASDAQ:QURE – Get Free Report) have received a consensus rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating on the […] - 2025-02-06 05:00:57
iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc QURE holdings
| Date | Number of QURE Shares Held | Base Market Value of QURE Shares | Local Market Value of QURE Shares | Change in QURE Shares Held | Change in QURE Base Value | Current Price per QURE Share Held | Previous Price per QURE Share Held |
|---|
| 2025-09-26 (Friday) | 7,002 | USD 380,279 | USD 380,279 | | | | |
| 2025-09-25 (Thursday) | 7,002 | USD 368,655 | USD 368,655 | 0 | USD 36,060 | USD 52.65 | USD 47.5 |
| 2025-09-24 (Wednesday) | 7,002 | USD 332,595 | USD 332,595 | | | | |
| 2025-09-17 (Wednesday) | 6,958 | USD 98,525 | USD 98,525 | 0 | USD -2,157 | USD 14.16 | USD 14.47 |
| 2025-09-16 (Tuesday) | 6,958 | USD 100,682 | USD 100,682 | | | | |
| 2025-09-12 (Friday) | 6,914 | USD 113,977 | USD 113,977 | | | | |
| 2025-09-11 (Thursday) | 6,914 | USD 117,123 | USD 117,123 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of QURE by Blackrock for IE00B3VWM098
Show aggregate share trades of QURE| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-08-21 | SELL | -22 | | | 15.550* | | 14.65 Profit of 322 on sale |
| 2025-07-31 | BUY | 66 | | | 13.920* | | 14.64 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of QURE
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 318,371 | 0 | 552,526 | 57.6% |
| 2025-09-18 | 239,746 | 0 | 508,307 | 47.2% |
| 2025-09-17 | 250,676 | 3,211 | 512,403 | 48.9% |
| 2025-09-16 | 226,200 | 7,479 | 488,784 | 46.3% |
| 2025-09-15 | 1,006,907 | 8,896 | 1,663,718 | 60.5% |
| 2025-09-12 | 76,438 | 320 | 271,891 | 28.1% |
| 2025-09-11 | 92,260 | 0 | 323,503 | 28.5% |
| 2025-09-10 | 80,557 | 0 | 321,207 | 25.1% |
| 2025-09-09 | 169,078 | 0 | 331,643 | 51.0% |
| 2025-09-08 | 196,897 | 830 | 532,970 | 36.9% |
| 2025-09-05 | 545,994 | 0 | 1,249,601 | 43.7% |
| 2025-09-04 | 128,768 | 0 | 375,712 | 34.3% |
| 2025-09-03 | 194,785 | 8 | 647,015 | 30.1% |
| 2025-09-02 | 134,964 | 0 | 585,954 | 23.0% |
| 2025-08-29 | 150,710 | 1,006 | 258,556 | 58.3% |
| 2025-08-28 | 163,067 | 0 | 520,913 | 31.3% |
| 2025-08-27 | 83,358 | 0 | 179,190 | 46.5% |
| 2025-08-26 | 70,531 | 1 | 135,861 | 51.9% |
| 2025-08-25 | 67,140 | 0 | 139,253 | 48.2% |
| 2025-08-22 | 90,341 | 700 | 528,219 | 17.1% |
| 2025-08-21 | 86,797 | 0 | 420,383 | 20.6% |
| 2025-08-20 | 96,859 | 100 | 165,461 | 58.5% |
| 2025-08-19 | 122,859 | 291 | 270,537 | 45.4% |
| 2025-08-18 | 95,382 | 0 | 227,461 | 41.9% |
| 2025-08-15 | 184,172 | 1,751 | 446,159 | 41.3% |
| 2025-08-14 | 158,615 | 1,100 | 612,145 | 25.9% |
| 2025-08-13 | 95,335 | 5,115 | 216,405 | 44.1% |
| 2025-08-12 | 153,470 | 19,303 | 335,019 | 45.8% |
| 2025-08-11 | 421,439 | 6,113 | 632,514 | 66.6% |
| 2025-08-08 | 104,884 | 1,500 | 171,550 | 61.1% |
| 2025-08-07 | 128,206 | 0 | 245,880 | 52.1% |
| 2025-08-06 | 139,996 | 0 | 301,278 | 46.5% |
| 2025-08-05 | 204,717 | 144 | 757,591 | 27.0% |
| 2025-08-04 | 144,853 | 0 | 301,268 | 48.1% |
| 2025-08-01 | 129,384 | 0 | 304,756 | 42.5% |
| 2025-07-31 | 266,949 | 300 | 513,121 | 52.0% |
| 2025-07-30 | 531,544 | 40,855 | 1,489,796 | 35.7% |
| 2025-07-29 | 889,600 | 28,559 | 1,625,471 | 54.7% |
| 2025-07-28 | 178,706 | 561 | 252,787 | 70.7% |
| 2025-07-25 | 164,372 | 0 | 238,949 | 68.8% |
| 2025-07-24 | 202,668 | 0 | 363,836 | 55.7% |
| 2025-07-23 | 358,715 | 0 | 866,421 | 41.4% |
| 2025-07-22 | 272,275 | 114 | 472,026 | 57.7% |
| 2025-07-21 | 142,949 | 0 | 304,017 | 47.0% |
| 2025-07-18 | 338,606 | 1,158 | 547,749 | 61.8% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.